Laura Fox, PA
Physician Assistant · Grand Island, NENPI 1023078425
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 439 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 28.4% of the total. Among physician assistant clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 439 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sun Pharmaceutical Industries Inc.$729
- Johnson & Johnson$696
- Lilly USA, LLC$559
- Novartis$553
- E.r. Squibb & Sons, L.L.C.$384
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,80595%
- Education$3625%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 133 | $2,038 |
| Sun Pharmaceutical Industries Inc. | 45 | $729 |
| Johnson & Johnson | 33 | $696 |
| Lilly USA, LLC | 39 | $559 |
| Novartis | 34 | $553 |
| E.r. Squibb & Sons, L.L.C. | 33 | $384 |
| UCB, Inc. | 22 | $372 |
| Amgen | 22 | $361 |
| Regeneron Healthcare Solutions, Inc. | 15 | $353 |
| Sanofi | 13 | $225 |
| Incyte Corporation | 12 | $204 |
| Pfizer | 8 | $124 |
| Sandoz | 5 | $96 |
| LEO Pharma Inc. | 4 | $84 |
| Convatec Inc. | 3 | $77 |
| Boston Scientific | 1 | $50 |
| Boehringer Ingelheim | 3 | $50 |
| Galderma Laboratories, L.p. | 3 | $46 |
| Arcutis Biotherapeutics, Inc. | 3 | $45 |
| Dermavant Sciences, Inc. | 3 | $41 |
| Smith+Nephew | 1 | $26 |
| Medtronic | 1 | $19 |
| Almirall LLC | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $12 |
| Organon | 1 | $7 |
How this compares
$7,167 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 22 | $86,907 |
| Ketoconazole | 188 | $4,825 |
| Tacrolimus | 26 | $3,468 |
| Clobetasol Propionate | 48 | $2,609 |
| Fluorouracil | 28 | $2,208 |
| Mometasone Furoate | 34 | $950 |
| Hydroxychloroquine Sulfate | 18 | $630 |
| Clindamycin Phosphate | 11 | $432 |
| Mupirocin | 41 | $314 |
| Doxycycline Hyclate | 23 | $292 |
| Triamcinolone Acetonide | 44 | $271 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Grand Island
- Joel JasaGrand Island$18K
- Jacqueline BeaverGrand Island$8K
- Megan SchrinerGrand Island$8K
- Christopher LinkeGrand Island$8K
- Susan Retzlaff DeitrickGrand Island$6K
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.